Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
In Vitro Enzyme IC50 Assay from US Patent US20240207292: "BORONIC ACID COMPOUNDS, COMPOSITIONS AND METHODS"
Assay data:93 Active, 7 Activity ≤ 1 nM, 93 Activity ≤ 1 µM, 93 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Measurement of Binding Affinity for Human ABHD6 from US Patent US11981682: "Substituted cyclopenta[c]pyrroles as ABHD6 antagonists"
Assay data:20 Active, 4 Activity ≤ 1 nM, 20 Activity ≤ 1 µM, 20 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Evaluation of ABHD6 Enzyme Inhibitory Activity from US Patent US11981682: "Substituted cyclopenta[c]pyrroles as ABHD6 antagonists"
Assay data:20 Active, 14 Activity ≤ 1 nM, 20 Activity ≤ 1 µM, 20 Tested
DPP4 activity assay from US Patent US20240115577: "SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES"
Assay data:25 Active, 9 Activity ≤ 1 nM, 25 Activity ≤ 1 µM, 25 Tested
hABHD12 Endocannabinoid related and lipase panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
hABHD6 Endocannabinoid related and lipase panel
hFAAH Endocannabinoid related and lipase panel
Assay data:1 Active, 1 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Inhibition of Fatty acid synthase in chicken liver using [3H]-acetyl CoA as substrate preincubated for 30 mins followed by substrate addition and measured after 10 mins in presence of NADPH by scintillation counting analysis
Assay data:5 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of mouse DPP4
Inhibition of human HSL
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human recombinant DPP-4 at 25 uM using Gly-Pro-Aminomethylcoumarin as substrate by Spectra max fluorometer analysis relative to control
Inhibition of human recombinant DPP-4 at 10 uM using Gly-Pro-Aminomethylcoumarin as substrate by Spectra max fluorometer analysis relative to control
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of human recombinant DPP-4 at 100 uM using Gly-Pro-Aminomethylcoumarin as substrate by Spectra max fluorometer analysis relative to control
Assay data:6 Tested
Inhibition of human recombinant DPP-4 at 10 uM relative to control
Binding affinity to DPP-4 (unknown origin) assessed as inhibition constant
Assay data:2 Active, 2 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human recombinant DPP-4 using H-Gly-Pro-aminomethylcoumarin as substrate at 100 uM relative to control
Assay data:2 Tested
Inhibition of human recombinant DPP-4 using H-Gly-Pro-aminomethylcoumarin as substrate
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of DPP-4 (unknown origin) at 100 uM relative to control
Assay data:4 Tested
Inhibition of DPP-4 (unknown origin) using (H-Gly-Pro-AMC) as substrate
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of human recombinant DPP-9
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on